CN104013699B - 一种治疗肝阳上亢型高血压病的药物组合物 - Google Patents
一种治疗肝阳上亢型高血压病的药物组合物 Download PDFInfo
- Publication number
- CN104013699B CN104013699B CN201410269411.0A CN201410269411A CN104013699B CN 104013699 B CN104013699 B CN 104013699B CN 201410269411 A CN201410269411 A CN 201410269411A CN 104013699 B CN104013699 B CN 104013699B
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- liver
- yang
- present
- treating hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 30
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 21
- 208000013403 hyperactivity Diseases 0.000 title description 4
- 239000003814 drug Substances 0.000 claims abstract description 26
- 241001601725 Sthenias Species 0.000 claims description 15
- 239000002775 capsule Substances 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 9
- 230000001631 hypertensive effect Effects 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims 2
- 238000002360 preparation method Methods 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 235000002566 Capsicum Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 239000006002 Pepper Substances 0.000 abstract 1
- 235000016761 Piper aduncum Nutrition 0.000 abstract 1
- 235000017804 Piper guineense Nutrition 0.000 abstract 1
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 235000008184 Piper nigrum Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000843 powder Substances 0.000 description 18
- 238000002156 mixing Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- 241000005787 Cistanche Species 0.000 description 9
- 235000003143 Panax notoginseng Nutrition 0.000 description 9
- 241000180649 Panax notoginseng Species 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- -1 filters Substances 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000012567 medical material Substances 0.000 description 6
- 238000010298 pulverizing process Methods 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 238000001291 vacuum drying Methods 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000035487 diastolic blood pressure Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000035488 systolic blood pressure Effects 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- ZPBWCRDSRKPIDG-UHFFFAOYSA-N amlodipine benzenesulfonate Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl ZPBWCRDSRKPIDG-UHFFFAOYSA-N 0.000 description 2
- 229960004005 amlodipine besylate Drugs 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009530 blood pressure measurement Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 108010061435 Enalapril Proteins 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
- 229960000873 enalapril Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
组别 | 例数 | 治愈 | 有效 | 无效 |
治疗组 | 180 | 160 | 17 | 3 |
对照组 | 100 | 80 | 12 | 8 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410269411.0A CN104013699B (zh) | 2014-06-17 | 2014-06-17 | 一种治疗肝阳上亢型高血压病的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410269411.0A CN104013699B (zh) | 2014-06-17 | 2014-06-17 | 一种治疗肝阳上亢型高血压病的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104013699A CN104013699A (zh) | 2014-09-03 |
CN104013699B true CN104013699B (zh) | 2015-05-06 |
Family
ID=51430882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410269411.0A Expired - Fee Related CN104013699B (zh) | 2014-06-17 | 2014-06-17 | 一种治疗肝阳上亢型高血压病的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104013699B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526345A (zh) * | 2012-03-17 | 2012-07-04 | 许从玉 | 一种治疗高血压的中药组合物 |
CN103405574A (zh) * | 2013-07-31 | 2013-11-27 | 唐国萍 | 一种治疗高血压的药物组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103417682B (zh) * | 2013-08-09 | 2014-09-17 | 田艺儿 | 一种降血压中药制剂及其制备方法 |
-
2014
- 2014-06-17 CN CN201410269411.0A patent/CN104013699B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526345A (zh) * | 2012-03-17 | 2012-07-04 | 许从玉 | 一种治疗高血压的中药组合物 |
CN103405574A (zh) * | 2013-07-31 | 2013-11-27 | 唐国萍 | 一种治疗高血压的药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN104013699A (zh) | 2014-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109674958B (zh) | 一种具有降尿酸功效的中药组合物及其制备方法和应用 | |
CN110787233B (zh) | 保肝中药组合物及其提取物和制药用途 | |
CN104338062A (zh) | 一种治疗腹痛、腹泻的中药制剂 | |
CN104027529A (zh) | 一种调节血脂、血压、血糖的中药组合物及其制备方法 | |
CN104173950B (zh) | 一种治疗前列腺癌的中草药组合物 | |
CN105287812A (zh) | 一种治疗肠易激综合征的药物组合物及其用途 | |
CN104721256A (zh) | 一种安胃疡提取物及其制备方法和医药用途 | |
CN104013699B (zh) | 一种治疗肝阳上亢型高血压病的药物组合物 | |
CN104225016B (zh) | 一种治疗脾胃虚弱型慢性萎缩性胃炎的药物组合物 | |
CN103041081A (zh) | 一种治疗脾虚腹泻型肠易激综合症的药物组合物及其制备方法 | |
CN103393938B (zh) | 一种降血糖的中药组合物 | |
CN105194355A (zh) | 一种治疗原发性高血压的中药制剂 | |
CN105833055A (zh) | 一种治疗“三高”的中药组合物、其制备方法和应用 | |
CN101700270A (zh) | 一种用于神经衰弱的中药组合物及其制备方法和质量控制方法 | |
CN104983759A (zh) | 一种治疗糖尿病肾病的中药组合物及其制备方法 | |
CN103920023A (zh) | 一种治疗高血压的中药 | |
CN101879227B (zh) | 一种治疗腰椎间盘突出症的中药组合物及其制备方法 | |
CN109200108B (zh) | 治疗抑郁症中药组合物及其制备方法和用途 | |
CN105943860A (zh) | 一种用于治疗糖尿病的药物制剂及其制备方法 | |
CN104189314A (zh) | 一种治疗痰浊阻遏证高血脂的药物组合物 | |
CN105853582A (zh) | 一种含有艾叶的治疗胆石症的药物制剂及其制备方法 | |
CN105362703A (zh) | 一种治疗原发性高血压的中药组合物及其制备方法 | |
CN105250749A (zh) | 一种治疗甲状腺腺瘤的中药及其制备方法 | |
CN105012808A (zh) | 一种治疗痛风的药物制剂 | |
CN104784651A (zh) | 一种制备用于治疗胃溃疡的药物制剂的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LIANG CUNFU Free format text: FORMER OWNER: LIU QINGZHEN Effective date: 20150408 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Liang Cunfu Inventor before: Liu Qingzhen |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU QINGZHEN TO: LIANG CUNFU |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150408 Address after: 276000 Shandong province Lanshan District Linyi city Jiefang Road No. 48 Applicant after: Liang Cunfu Address before: 276000 No. 56 Industrial Street, Luozhuang District, Shandong, Linyi Applicant before: Liu Qingzhen |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150506 Termination date: 20170617 |